News Conference News ESC 2019 BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI Caitlin E. Cox September 10, 2019
News Conference News ESC 2019 GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS Yael L. Maxwell September 10, 2019
News Conference News ESC 2019 TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization L.A. McKeown September 09, 2019
News Conference News ESC 2019 Young MI Patients’ Ischemic Risk Extends at Least Two Decades Caitlin E. Cox September 06, 2019
News Conference News ESC 2019 Ten-Year SYNTAXES Results Fix Roles for CABG, PCI in Complex CAD Shelley Wood September 05, 2019
News Conference News ESC 2019 Stopped Early, DAPA Offers Insight on ICD Timing After STEMI Shelley Wood September 04, 2019
News Conference News ESC 2019 Transfer for Primary PCI Still Better Than Fibrinolysis After 16 Years: DANAMI-2 Todd Neale September 04, 2019
News Conference News ESC 2019 Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART Yael L. Maxwell September 04, 2019
News Conference News ESC 2019 Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT Michael O'Riordan September 03, 2019
News Conference News ESC 2019 Another Step Forward for Genotype-Guided Prescribing After PCI: POPular Genetics Yael L. Maxwell September 03, 2019
Presentation ESC 2019 Temporal Trends in Incidence and Outcome of Acute Coronary Syndrome Presenter: Johannes Neumann September 01, 2019
News Conference News ESC 2019 Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5 Shelley Wood September 01, 2019
News Conference News ESC 2019 CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI Yael L. Maxwell September 01, 2019
News Conference News ESC 2019 Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS Michael O'Riordan September 01, 2019
News Conference News ESC 2019 HiSTORIC Trial Supports Single-Test Rule-Out of MI Using High-Sensitivity Troponin Todd Neale September 01, 2019
Presentation ESC 2019 A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes Presenter: David B. Brieger September 01, 2019
News Conference News ESC 2019 COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter Yael L. Maxwell September 01, 2019
News Conference News ESC 2019 POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients Michael O'Riordan August 31, 2019
News Conference News ESC 2019 Evolocumab in Acute ACS Safely Reduces LDL Cholesterol: EVOPACS Yael L. Maxwell August 31, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019